HURTHLE CELL THYROID NEOPLASIA

Clinical trials for HURTHLE CELL THYROID NEOPLASIA explained in plain language.

Never miss a new study

Get alerted when new HURTHLE CELL THYROID NEOPLASIA trials appear

Sign up with your email to follow new studies for HURTHLE CELL THYROID NEOPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo targets tough thyroid cancers

Disease control Ongoing

This study is testing whether combining an immunotherapy drug called PDR001 with other targeted cancer drugs is safe and effective for treating advanced thyroid cancer that no longer responds to standard radioactive iodine treatment. The trial includes 19 adults with specific typ…

Matched conditions: HURTHLE CELL THYROID NEOPLASIA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

HURTHLE CELL THYROID NEOPLASIA

Get alerted when new HURTHLE CELL THYROID NEOPLASIA trials appear

New drug combo targets tough thyroid cancers